Public annual accounts

DR & PARTNERS financials

A multi-period view of the public annual-account figures reported for DR & PARTNERS, with comparable measures and links to available source documents.

Company overview
Registry number

0820555860

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€52,064

+7.8%

EBITDA
€7,632

-63.2%

Total assets
€59,430

-18.6%

Equity
€15,601

-31.9%

EBITDA margin +14.7% · Equity ratio +26.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202530 Jun 2025€52,064€7,632€59,430€15,601-
202430 Jun 2024€48,295€20,712€73,004€22,921-
Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report